Marina Friling, Ana María García-Muñoz, Tania Perrinjaquet-Moccetti, Desirée Victoria-Montesinos, Silvia Pérez-Piñero, María Salud Abellán-Ruiz, Antonio J Luque-Rubia, Ana Isabel García-Guillén, Fernando Cánovas, Eran Ivanir
A single-center, crossover, randomized, double-blind, and controlled clinical study was conducted to assess the tolerability profile, especially with regard to gastrointestinal complaints, of oral supplementation with AB-Fortis® , a microencapsulated ferric saccharate (MFS), as compared with conventional ferrous sulphate (FS) in healthy premenopausal women. A dose of 60 mg/day of elemental iron was used. The test products were administered for 14 consecutive days with a washout period of two menstrual episodes and a minimum of one month between the two intervention periods...
October 14, 2022: International Journal of Molecular Sciences